Compare ACLX & SBCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACLX | SBCF |
|---|---|---|
| Founded | 2015 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.2B |
| IPO Year | 2022 | N/A |
| Metric | ACLX | SBCF |
|---|---|---|
| Price | $67.97 | $33.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $113.75 | $31.00 |
| AVG Volume (30 Days) | ★ 870.4K | 573.9K |
| Earning Date | 02-26-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | ★ 23.57 |
| EPS | N/A | ★ 1.68 |
| Revenue | $35,898,000.00 | ★ $556,541,000.00 |
| Revenue This Year | N/A | $33.11 |
| Revenue Next Year | $309.32 | $29.90 |
| P/E Ratio | ★ N/A | $20.70 |
| Revenue Growth | N/A | ★ 12.63 |
| 52 Week Low | $47.86 | $21.36 |
| 52 Week High | $94.07 | $35.46 |
| Indicator | ACLX | SBCF |
|---|---|---|
| Relative Strength Index (RSI) | 49.04 | 54.06 |
| Support Level | $66.00 | $33.03 |
| Resistance Level | $76.50 | $35.46 |
| Average True Range (ATR) | 3.50 | 1.02 |
| MACD | 0.85 | 0.13 |
| Stochastic Oscillator | 46.58 | 47.63 |
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.